Cognyte Announces Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cogentix Medical (CGNT) Tops Q3 EPS by 11c
December 21, 2021 7:34 AM ESTCogentix Medical (NASDAQ: CGNT) reported Q3 EPS of $0.21, $0.11 better than the analyst estimate of $0.10. Revenue for the quarter came in at $118.4 million versus the consensus estimate of $114.83 million.
GUIDANCE:
Cogentix Medical sees FY2022 EPS of $0.80, versus the consensus of $0.88. Cogentix... More
